Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases.

The Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune Diseases has generated a series of guidelines for the laboratory diagnosis and monitoring of systemic autoimmune rheumatic diseases intendedfor the use of clinical pathologists and laboratory physicians. These guidelines are based on a systematic review of published works and expert panel discussion and consist of 13 recommendations for antinuclear antibodies, anti-double-stranded native DNA, and antinuclear specific antibodies. To improve analytic performances and help select the most appropriate test for specific autoantibodies, as well as provide education and guidance in the use of these tests, special emphasis is placed on laboratory methods.

[1]  R. Nakamura,et al.  Importance of detection of ss‐a/ro autoantibody in screening immunofluorescence tests for autoantibodies to nuclear antigens , 1991, Journal of clinical laboratory analysis.

[2]  A. Russell,et al.  Relative value of commercial kits for ANA testing. , 2003, Clinical and experimental rheumatology.

[3]  A Kavanaugh,et al.  Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.

[4]  T. Mimori Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. , 1999, Internal medicine.

[5]  S. Platzgummer,et al.  Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies , 2005, Clinical Rheumatology.

[6]  S. Adelstein,et al.  Autoantibodies to Extractable Nuclear Antigens: Making Detection and Interpretation More Meaningful , 2002, Clinical and Vaccine Immunology.

[7]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[8]  W. Egner The use of laboratory tests in the diagnosis of SLE , 2000, Journal of clinical pathology.

[9]  S. Lapointe,et al.  Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. , 1991, Arthritis and rheumatism.

[10]  M M HARGRAVES,et al.  Presentation of two bone marrow elements; the tart cell and the L.E. cell. , 1948, Proceedings of the staff meetings. Mayo Clinic.

[11]  A. Wiik,et al.  Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. , 2004, Clinical and experimental rheumatology.

[12]  D. Isenberg,et al.  Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? , 2002, Lupus.

[13]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[14]  B. Mazières,et al.  Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. , 1996, The Journal of rheumatology.

[15]  R. Bogusky,et al.  An enzyme immunoassay screening test for the detection of total antinuclear antibodies , 1991, Journal of clinical laboratory analysis.

[16]  J. Koziol,et al.  A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. , 2003, The Journal of rheumatology.

[17]  V. Aidinis,et al.  Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods. , 1993, British journal of rheumatology.

[18]  N. Bizzaro,et al.  Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. , 1998, Journal of immunological methods.

[19]  S. Kondo,et al.  Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. , 2001, Clinical chemistry.

[20]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[21]  E. Tan,et al.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.

[22]  M. Baldwin,et al.  Setting the scene. , 2013, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[23]  I. Peene,et al.  Sensitivity of the HEp-2000 Substrate for the Detection of Anti-SSA/Ro60 Antibodies , 2000, Clinical Rheumatology.

[24]  O. Rekvig,et al.  Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity , 2004, Annals of the rheumatic diseases.

[25]  R. Maini,et al.  Manual of Biological Markers of Disease , 1996, Springer Netherlands.

[26]  T. Sato,et al.  Classification criteria for polymyositis and dermatomyositis. , 1995, The Journal of rheumatology.

[27]  I. Kushner,et al.  An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA. , 1977, Arthritis and rheumatism.

[28]  N. Bizzaro,et al.  Sensitivity and Specificity of Immunological Methods for the Detection of Anti-Topoisomerase I (Scl70) Autoantibodies: Results of a Multicenter Study , 2000 .

[29]  Richard E. Watts,et al.  Autoimmune Rheumatic Disease , 1999 .

[30]  R. Moore Evidence-Based Clinical Biochemistry , 1997, Annals of clinical biochemistry.

[31]  Evaluation of a new automated enzyme fluoroimmunoassay using recombinant plasmid dsDNA for the detection of anti‐dsDNA antibodies in SLE , 2002, Journal of clinical laboratory analysis.

[32]  P. Limburg,et al.  Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies. , 1996, Scandinavian journal of rheumatology.

[33]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[34]  P. Utz Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus , 2004, Lupus.

[35]  T. Feltkamp,et al.  Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern. , 1988, Annals of the rheumatic diseases.

[36]  G. Jacob,et al.  Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. , 1998, Archives of pathology & laboratory medicine.

[37]  R. H. Scofield,et al.  SS-A (Ro) Autoantibodies , 1996 .

[38]  R. Humbel,et al.  Detection of antinuclear antibodies by immunofluorescence , 1996 .

[39]  Charles Pj,et al.  The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992. , 1992 .

[40]  M. Reichlin,et al.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus. , 1981, Medicine.

[41]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[42]  R. Sinico,et al.  The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. , 2002, Journal of nephrology.

[43]  R. Shmerling,et al.  Antinuclear Antibody Testing: A Study of Clinical Utility , 1996 .

[44]  L. Aarden,et al.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[45]  E. Tan,et al.  Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.

[46]  E. Tan,et al.  Standards of care: the value and importance of standardization. , 1997, Arthritis and rheumatism.

[47]  P. Limburg,et al.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.

[48]  J. Jarvis,et al.  Clinical utility of antinuclear antibody tests in children , 2004, BMC pediatrics.

[49]  M. Reichlin,et al.  Heterogeneity of the Ro/SSA antigen and autoanti‐Ro/SSA response: evidence of the four antigenically distinct forms , 1990, Clinical and experimental immunology.

[50]  J. Buyon,et al.  The SS-A/Ro antigen , 1996 .

[51]  Daniel H Solomon,et al.  Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. , 2002, Arthritis and rheumatism.

[52]  D. Stott,et al.  Immunoblotting and dot blotting , 1989, Journal of Immunological Methods.

[53]  F J López-Longo,et al.  Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system , 2003, Lupus.

[54]  A. Wiik,et al.  The use and abuse of commercial kits used to detect autoantibodies , 2003, Arthritis research & therapy.

[55]  M. Fritzler,et al.  Detection of autoantibodies to ss‐a/ro by indirect immunofluorescence using a transfected and overexpressed human 60 kd ro autoantigen in hep‐2 cells , 1995, Journal of clinical laboratory analysis.

[56]  T. Jaskowski,et al.  Screening for antinuclear antibodies by enzyme immunoassay. , 1996, American journal of clinical pathology.

[57]  J. Buyon,et al.  Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. , 2003, Seminars in arthritis and rheumatism.

[58]  J. Koziol,et al.  A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. , 1999, Arthritis and rheumatism.

[59]  M. Fritzler,et al.  Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. , 1985, Clinical immunology and immunopathology.

[60]  E. Mozes,et al.  Detection of antigens in immune complexes by a dot blot assay. , 1995, Journal of immunological methods.

[61]  X. Bossuyt Evaluation of Two Automated Enzyme Immunoassays for Detection of Antinuclear Antibodies , 2000, Clinical chemistry and laboratory medicine.

[62]  D. Estes,et al.  Antinuclear antibodies. , 1972, Pathobiology annual.

[63]  R. Tubbs,et al.  Current concepts and advances in clinical laboratory testing for autoimmune diseases. , 1997, Critical reviews in clinical laboratory sciences.

[64]  Nicola Bizzaro,et al.  Diagnostic Accuracy of Elisa Methods as an Alternative Screening Test to Indirect Immunofluorescence for the Detection of Antinuclear Antibodies. Evaluation of Five Commercial Kits , 2004, Autoimmunity.

[65]  Insoo Kang,et al.  Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies , 2004, Clinical Rheumatology.

[66]  Antonella Afeltra,et al.  Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay , 2004, Clinical chemistry and laboratory medicine.

[67]  P. Solís,et al.  [Diagnosis of autoimmune diseases in hematology]. , 1985, Anales espanoles de pediatria.

[68]  D. Stites,et al.  Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay , 1997, Clinical and diagnostic laboratory immunology.

[69]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[70]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[71]  W Emlen,et al.  Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. , 1997, Arthritis and rheumatism.

[72]  D. Alarcón-Segovia,et al.  Reference reagents for antinuclear antibodies , 1988 .

[73]  H. Peeters Protides of the Biological Fluids , 1958 .

[74]  I. Peene,et al.  Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. , 2002, Clinical chemistry.

[75]  Y. Takasaki,et al.  Clinical significance of autoantibodies to PCNA , 1996 .

[76]  Harry R. Hill,et al.  Evaluation of Multiplexed Fluorescent Microsphere Immunoassay for Detection of Autoantibodies to Nuclear Antigens , 2004, Clinical Diagnostic Laboratory Immunology.

[77]  E. Bonifacio,et al.  Use of a standard curve improves precision and concordance of antinuclear antibody measurement. , 1987, Journal of clinical & laboratory immunology.

[78]  Frank E. Young,et al.  Deoxyribonucleic Acid Antibody: A Method to Detect Its Primary Interaction with Deoxyribonucleic Acid , 1968, Science.

[79]  S. Ballou,et al.  Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[80]  E. Tan International cooperative activities in standardization of antinuclear antibodies , 1996 .

[81]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[82]  E. Tan,et al.  Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. , 1985, American journal of clinical pathology.

[83]  L. Aarden,et al.  Prognostic value of anti-dsDNA in SLE. , 1982, Annals of the rheumatic diseases.

[84]  Andrea Giordano,et al.  Autoantibodies Profile in the Sera of Patients with Sjogren]s Syndrome: The ANA Evaluation—A Homogeneous, Multiplexed System , 2004, Clinical & developmental immunology.

[85]  M. Satoh,et al.  Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. , 1994, Rheumatic diseases clinics of North America.

[86]  A. Wiik,et al.  Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. , 2004, Arthritis and rheumatism.

[87]  M. Zeher,et al.  Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). , 2003, Clinical and experimental rheumatology.

[88]  P. Schur,et al.  Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. , 2004, Arthritis and rheumatism.

[89]  Hiroshi Watanabe,et al.  Detection of anti‐nuclear antibodies from patients with systemic rheumatic diseases by elisa using hep‐2 cell nuclei , 1991, Journal of clinical laboratory analysis.

[90]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[91]  Thomas Skogh,et al.  Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. , 2004, Journal of autoimmunity.

[92]  R. Smeenk Measurement of antibodies to DNA , 1996 .

[93]  W. Venrooij Autoantigens in Connective Tissue Diseases , 1994 .

[94]  Allan Wiik,et al.  Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. , 2004, Clinical chemistry.

[95]  G. Panayi Immunology of the Connective Tissue Diseases , 1994, Immunology and Medicine Series.

[96]  O. Rekvig,et al.  Antinuclear antibody screening in this new millennium: farewell to the microscope? , 2001, Scandinavian journal of rheumatology.

[97]  P. Limburg,et al.  Prevention of relapses in systemic lupus erythematosus , 1995, The Lancet.

[98]  P. Dans Credibility, Cookbook Medicine, and Common Sense: Guidelines and the College , 1994, Annals of Internal Medicine.

[99]  L. Leiva,et al.  Antinuclear Antibody (ANA) and ANA Profile Tests in Children with Autoimmune Disorders: A Retrospective Study , 2000, Clinical Rheumatology.

[100]  T. E. W. Feltkamp,et al.  Standards and reference preparations , 1996 .

[101]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[102]  R. Westhovens,et al.  Detection of anti-SSA antibodies by indirect immunofluorescence. , 2004, Clinical chemistry.

[103]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[104]  A. Coutinho,et al.  Natural autoantibodies. , 1995, Current opinion in immunology.

[105]  E. Karlson,et al.  Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[106]  K. Moder Use and interpretation of rheumatologic tests: a guide for clinicians. , 1996, Mayo Clinic proceedings.

[107]  Y. Hamashima Antinuclear antibodies in systemic lupus erythematosus. , 1965, Acta pathologica japonica.

[108]  E. Tan,et al.  Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. , 1995, Journal of autoimmunity.

[109]  W. V. van Venrooij,et al.  The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. , 1991, Journal of immunological methods.